to assess the t2dm progression after curcumin treatments and to determine the number of subjects progressing to t2dm, changes in β-cell functions (homeostasis model assessment [homa]-β, c-peptide, and proinsulin/insulin), insulin resistance (homa-ir), anti-inflammatory cytokine (adiponectin), and other parameters were monitored at the baseline and at 3-, 6-, and 9-month visits during the course of intervention.